Literature DB >> 21110315

The growing diversity and spectrum of action of myeloid-derived suppressor cells.

Alberto Mantovani1.   

Abstract

Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of myelomonocytic cells endowed with suppressive activity. MDSC expand and acquire suppressive functions in chronic inflammatory conditions, in particular in neoplastic disorders. As exemplified in two reports in this issue of the European Journal of Immunology, progress has been made in defining MDSC-inducing signals, MDSC phenotypic diversity and spectrum of action. These recent results provide a basis to better define the relationship of MDSC with the adaptive immune responses of mononuclear phagocytes and neutrophils and to exploit their function in a therapeutic setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110315     DOI: 10.1002/eji.201041170

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

Review 1.  Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion.

Authors:  Sheinei J Saleem; Daniel H Conrad
Journal:  Int Immunopharmacol       Date:  2011-03-21       Impact factor: 4.932

2.  Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner.

Authors:  Tillmann Michels; Galina V Shurin; Hiam Naiditch; Alexandra Sevko; Viktor Umansky; Michael R Shurin
Journal:  J Immunotoxicol       Date:  2012-01-28       Impact factor: 3.000

Review 3.  Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.

Authors:  Oana Draghiciu; Joyce Lubbers; Hans W Nijman; Toos Daemen
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

4.  Regulatory T Cells, Frailty, and Immune Activation in Men Who Have Sex With Men in the Multicenter AIDS Cohort Study.

Authors:  Weiying Zhang; Tricia L Nilles; Jacquett R Johnson; Joseph B Margolick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-22       Impact factor: 6.053

5.  Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD.

Authors:  N Rieber; I Wecker; D Neri; K Fuchs; I Schäfer; A Brand; M Pfeiffer; P Lang; W Bethge; O Amon; R Handgretinger; D Hartl
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

Review 6.  A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.

Authors:  Christopher Shipp; Lisa Speigl; Nicole Janssen; Alexander Martens; Graham Pawelec
Journal:  Cell Mol Life Sci       Date:  2016-05-28       Impact factor: 9.261

7.  Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis.

Authors:  David B Vaught; Jamie C Stanford; Rebecca S Cook
Journal:  Cancer Cell Microenviron       Date:  2015

8.  Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeutics.

Authors:  David A Knorr; Aaron D Goldberg; Eytan M Stein; Martin S Tallman
Journal:  Leuk Lymphoma       Date:  2019-07-23

9.  Tumor-Independent Host Secretomes Induced By Angiogenesis and Immune-Checkpoint Inhibitors.

Authors:  Michalis Mastri; Christina R Lee; Amanda Tracz; Robert S Kerbel; Melissa Dolan; Yuhao Shi; John M L Ebos
Journal:  Mol Cancer Ther       Date:  2018-04-25       Impact factor: 6.261

Review 10.  IL-1 and IL-1 regulatory pathways in cancer progression and therapy.

Authors:  Alberto Mantovani; Isabella Barajon; Cecilia Garlanda
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.